300519 新光药业
已收盘 09-24 15:00:00
资讯
新帖
简况
新光药业：省外市场拓展正在稳步推进中
证券之星 · 09-23 20:51
新光药业：省外市场拓展正在稳步推进中
9月21日新光药业涨5.46%，工银聚享混合A基金重仓该股
证券之星 · 09-21
9月21日新光药业涨5.46%，工银聚享混合A基金重仓该股
9月3日新光药业发布公告，股东减持79.7万股
证券之星 · 09-03
9月3日新光药业发布公告，股东减持79.7万股
新光药业（300519）2026年中报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 08-26
新光药业（300519）2026年中报简析：营收净利润同比双双增长，三费占比上升明显
新光药业(300519)6月30日股东户数1.36万户，较上期减少8.76%
证券之星 · 08-25
新光药业(300519)6月30日股东户数1.36万户，较上期减少8.76%
新光药业（300519）披露2026年1-6月非经营性资金占用及其他关联资金往来情况表，8月24日股价下跌1.47%
证券之星 · 08-24
新光药业（300519）披露2026年1-6月非经营性资金占用及其他关联资金往来情况表，8月24日股价下跌1.47%
图解新光药业中报：第二季度单季净利润同比增长81.16%
证券之星 · 08-24
图解新光药业中报：第二季度单季净利润同比增长81.16%
股市必读：新光药业（300519）7月28日董秘有最新回复
证券之星 · 07-29
股市必读：新光药业（300519）7月28日董秘有最新回复
7月28日新光药业涨5.34%，工银聚享混合A基金重仓该股
证券之星 · 07-28
7月28日新光药业涨5.34%，工银聚享混合A基金重仓该股
7月27日新光药业涨5.48%，工银聚享混合A基金重仓该股
证券之星 · 07-27
7月27日新光药业涨5.48%，工银聚享混合A基金重仓该股
7月24日新光药业跌5.34%，工银聚享混合A基金重仓该股
证券之星 · 07-24
7月24日新光药业跌5.34%，工银聚享混合A基金重仓该股
股市必读：新光药业（300519）7月23日董秘有最新回复
证券之星 · 07-24
股市必读：新光药业（300519）7月23日董秘有最新回复
新光药业（300519）披露持股5%以上股东持股比例变动触及1%整倍数公告，7月2日股价上涨0.73%
证券之星 · 07-02
新光药业（300519）披露持股5%以上股东持股比例变动触及1%整倍数公告，7月2日股价上涨0.73%
股市必读：6月30日新光药业现1笔折价16.79%的大宗交易 合计成交200.16万元
证券之星 · 07-01
股市必读：6月30日新光药业现1笔折价16.79%的大宗交易 合计成交200.16万元
股市必读：6月29日新光药业现3笔折价22.29%的大宗交易 合计成交601.65万元
证券之星 · 06-30
股市必读：6月29日新光药业现3笔折价22.29%的大宗交易 合计成交601.65万元
6月22日新光药业现1笔折价20.61%的大宗交易 合计成交228.62万元
证券之星 · 06-22
6月22日新光药业现1笔折价20.61%的大宗交易 合计成交228.62万元
每周股票复盘：新光药业（300519）股东减持213.7万股占总股本1.3356%
证券之星 · 06-21
每周股票复盘：新光药业（300519）股东减持213.7万股占总股本1.3356%
6月15日新光药业发布公告，股东减持213.7万股
证券之星 · 06-15
6月15日新光药业发布公告，股东减持213.7万股
6月5日新光药业现4笔折价21.54%的大宗交易 合计成交1339.84万元
证券之星 · 06-05
6月5日新光药业现4笔折价21.54%的大宗交易 合计成交1339.84万元
新光药业（300519）披露2025年年度权益分派实施公告，5月21日股价下跌3.47%
证券之星 · 05-21
新光药业（300519）披露2025年年度权益分派实施公告，5月21日股价下跌3.47%
加载更多
公司概况
公司名称：
浙江新光药业股份有限公司
所属行业：
医药制造业
上市日期：
2016-06-24
主营业务：
浙江新光药业股份有限公司的主营业务是中成药、化学药、保健食品的研发、生产和销售。公司的主要产品是黄芪生脉饮、伸筋丹胶囊、西洋参口服液。
发行价格：
12.20
{"stockData":{"symbol":"300519","market":"SZ","secType":"STK","nameCN":"新光药业","latestPrice":14.56,"timestamp":1790233404000,"preClose":14.59,"halted":0,"volume":2053200,"delay":0,"changeRate":-0.0021,"floatShares":113999999,"shares":160000000,"eps":0.3876,"marketStatus":"已收盘","change":-0.03,"latestTime":"09-24 15:00:00","open":14.58,"high":14.8,"low":14.43,"amount":29948200,"amplitude":0.0254,"askPrice":14.56,"askSize":18,"bidPrice":14.55,"bidSize":384,"shortable":0,"etf":0,"ttmEps":0.3876,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790559000000},"marketStatusCode":5,"adr":0,"adjPreClose":14.59,"symbolType":"stock","openAndCloseTimeList":[[1790213400000,1790220600000],[1790226000000,1790233200000]],"highLimit":16.05,"lowLimit":13.13,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":160000000,"isCdr":false,"pbRate":2.82,"roa":"--","peRate":37.564499,"roe":"4.68%","epsLYR":0.34,"committee":0.17866,"marketValue":2330000000,"turnoverRate":0.018,"status":1,"floatMarketCap":1661000000},"requestUrl":"/m/hq/s/300519","defaultTab":"news","newsList":[{"id":"2669669486","title":"新光药业：省外市场拓展正在稳步推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2669669486","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669669486?lang=zh_cn&edition=full","pubTime":"2026-09-23 20:51","pubTimestamp":1790167919,"startTime":"0","endTime":"0","summary":"证券之星消息，新光药业09月22日在投资者关系平台上答复投资者关心的问题。公司董事会始终立足经营实际，审慎制定发展战略，根据行业环境、市场需求变化及时调整IPO 募投项目的投向，并按规定履行信息披露义务。公司持续深耕现有市场，省外市场拓展正在稳步推进中。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300038446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669159213","title":"9月21日新光药业涨5.46%，工银聚享混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2669159213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669159213?lang=zh_cn&edition=full","pubTime":"2026-09-21 16:46","pubTimestamp":1789980391,"startTime":"0","endTime":"0","summary":"证券之星消息，9月21日新光药业涨5.46%，收盘报14.68元，换手率3.44%，成交量3.93万手，成交额5683.17万元。重仓新光药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为工银瑞信基金的工银聚享混合A。工银聚享混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100021020.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664987172","title":"9月3日新光药业发布公告，股东减持79.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664987172","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664987172?lang=zh_cn&edition=full","pubTime":"2026-09-03 20:01","pubTimestamp":1788436882,"startTime":"0","endTime":"0","summary":"证券之星消息，9月3日新光药业发布公告《新光药业:关于公司持股5%以上股东股份减持计划届满的公告》，其股东嵊州市和丰投资股份有限公司于2026年8月25日至2026年9月2日间合计减持79.7万股，占公司目前总股本的0.4981%，变动期间该股股价上涨3.41%，截止9月2日收盘报14.56元。股东增减持详情见下表：根据新光药业2026年中报公布的十大股东详情如下：本文数据来源于新光药业公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300038193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662750493","title":"新光药业（300519）2026年中报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2662750493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662750493?lang=zh_cn&edition=full","pubTime":"2026-08-26 06:30","pubTimestamp":1787697021,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期新光药业发布2026年中报。截至本报告期末，公司营业总收入1.43亿元，同比上升1.17%，归母净利润3971.21万元，同比上升24.46%。本报告期新光药业三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达61.19%。营业利润变动幅度为25.86%,原因:营业成本减少、毛利率增加。本文数据来源于新光药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600010287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738254","title":"新光药业(300519)6月30日股东户数1.36万户，较上期减少8.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738254","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738254?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:53","pubTimestamp":1787651606,"startTime":"0","endTime":"0","summary":"证券之星消息，近日新光药业披露，截至2026年6月30日公司股东户数为1.36万户，较3月31日减少1308.0户，减幅为8.76%。在中药行业个股中，新光药业股东户数低于行业平均水平，截至6月30日，中药行业平均股东户数为5.3万户。从股价来看，2026年3月31日至2026年6月30日，新光药业区间跌幅为21.34%，在此期间股东户数减少1308.0户，减幅为8.76%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500037704.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300519","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661729522","title":"新光药业（300519）披露2026年1-6月非经营性资金占用及其他关联资金往来情况表，8月24日股价下跌1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661729522","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661729522?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:31","pubTimestamp":1787581887,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，新光药业报收于14.08元，较前一交易日下跌1.47%，最新总市值为22.53亿元。该股当日开盘14.17元，最高14.44元，最低13.94元，成交额达5571.5万元，换手率为3.46%。公告显示，公司编制了2026年1-6月非经营性资金占用及其他关联资金往来情况汇总表，表格包括控股股东、实际控制人及其附属企业、上市公司的子公司及其附属企业、其他关联方及其附属企业的资金往来情况。该报表由法定代表人、主管会计工作负责人及会计机构负责人签章。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400037590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661122026","title":"图解新光药业中报：第二季度单季净利润同比增长81.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661122026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661122026?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:15","pubTimestamp":1787566547,"startTime":"0","endTime":"0","summary":"证券之星消息，新光药业2026年中报显示，上半年度公司主营收入1.43亿元，同比上升1.17%；归母净利润3971.21万元，同比上升24.46%；扣非净利润3620.94万元，同比上升23.0%；其中2026年第二季度，公司单季度主营收入5412.38万元，同比上升13.48%；单季度归母净利润1334.41万元，同比上升81.16%；单季度扣非净利润1097.09万元，同比上升80.66%；负债率6.05%，投资收益353.95万元，财务费用-124.42万元，毛利率46.06%。财报数据概要请见下图:本文数据来源于新光药业2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026104.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655088113","title":"股市必读：新光药业（300519）7月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2655088113","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655088113?lang=zh_cn&edition=full","pubTime":"2026-07-29 01:38","pubTimestamp":1785260293,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，新光药业报收于13.8元，上涨5.34%，换手率9.19%，成交量10.49万手，成交额1.45亿元。董秘最新回复投资者： 请问截止目前，贵公司的股东户数是多少董秘： 您好，感谢您对本公司的关注。为保证信息披露的公平性，公司会在定期报告中对股东情况作出统一披露。交易信息汇总资金流向7月28日主力资金净流入400.09万元；游资资金净流入988.49万元；散户资金净流出1388.58万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900001164.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300519","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654444077","title":"7月28日新光药业涨5.34%，工银聚享混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654444077","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654444077?lang=zh_cn&edition=full","pubTime":"2026-07-28 16:56","pubTimestamp":1785228967,"startTime":"0","endTime":"0","summary":"证券之星消息，7月28日新光药业涨5.34%，收盘报13.8元，换手率9.19%，成交量10.49万手，成交额1.45亿元。重仓新光药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为工银瑞信基金的工银聚享混合A。工银聚享混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800027041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300519","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654013207","title":"7月27日新光药业涨5.48%，工银聚享混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654013207","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654013207?lang=zh_cn&edition=full","pubTime":"2026-07-27 16:50","pubTimestamp":1785142201,"startTime":"0","endTime":"0","summary":"证券之星消息，7月27日新光药业涨5.48%，收盘报13.1元，换手率5.17%，成交量5.9万手，成交额7633.18万元。重仓新光药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为工银瑞信基金的工银聚享混合A。工银聚享混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700021208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653700133","title":"7月24日新光药业跌5.34%，工银聚享混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653700133","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653700133?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:52","pubTimestamp":1784883168,"startTime":"0","endTime":"0","summary":"证券之星消息，7月24日新光药业跌5.34%，收盘报12.42元，换手率4.12%，成交量4.71万手，成交额5987.48万元。重仓新光药业的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为工银瑞信基金的工银聚享混合A。工银聚享混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400028982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300519","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653727698","title":"股市必读：新光药业（300519）7月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653727698","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653727698?lang=zh_cn&edition=full","pubTime":"2026-07-24 01:42","pubTimestamp":1784828534,"startTime":"0","endTime":"0","summary":"截至2026年7月23日收盘，新光药业报收于13.12元，上涨4.79%，换手率6.14%，成交量7.01万手，成交额8952.93万元。顺祝健康，快乐 【比如截至到2026年7月20日贵公司的股东人数是多少?您可以把带有时间和姓名的股票交易软件持仓截图和身份证一并扫描发送至公司投资者邮箱，我们将在核实后予以回复。当日关注点交易信息汇总：7月23日主力资金净流入368.64万元，游资资金净流出479.71万元，散户资金净流入111.07万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400001219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648506972","title":"新光药业（300519）披露持股5%以上股东持股比例变动触及1%整倍数公告，7月2日股价上涨0.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648506972","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648506972?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:48","pubTimestamp":1782985683,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，新光药业报收于12.5元，较前一交易日上涨0.73%，最新总市值为20亿元。公告显示，持股5%以上股东嵊州市和丰投资股份有限公司于2026年6月22日至6月30日通过大宗交易方式减持公司股份1,063,000股，占公司总股本的0.6644%。本次减持前，和丰投资持有公司股份21,862,900股，占总股本13.6643%；减持后持有20,799,900股，占总股本12.9999%，持股比例变动触及1%整数倍。本次减持属于此前披露的减持计划范围内，未违反相关承诺及规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200030472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648756767","title":"股市必读：6月30日新光药业现1笔折价16.79%的大宗交易 合计成交200.16万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2648756767","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648756767?lang=zh_cn&edition=full","pubTime":"2026-07-01 05:22","pubTimestamp":1782854533,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，新光药业报收于11.85元，下跌3.58%，换手率2.07%，成交量2.36万手，成交额2822.98万元。当日关注点交易信息汇总：6月30日新光药业主力资金净流出149.55万元，游资资金净流入188.83万元； 交易信息汇总：当日发生1笔折价16.79%的大宗交易，成交金额200.16万元。大宗交易6月30日新光药业发生1笔大宗交易，折价率16.79%，成交金额200.16万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100006136.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647301147","title":"股市必读：6月29日新光药业现3笔折价22.29%的大宗交易 合计成交601.65万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647301147","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647301147?lang=zh_cn&edition=full","pubTime":"2026-06-30 03:06","pubTimestamp":1782759974,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，新光药业报收于12.29元，上涨3.02%，换手率2.75%，成交量3.14万手，成交额3790.62万元。交易信息汇总资金流向6月29日主力资金净流入54.6万元，占总成交额0.0%；游资资金净流出20.28万元，占总成交额0.0%；散户资金净流出34.32万元，占总成交额0.0%。大宗交易6月29日新光药业现3笔折价22.29%的大宗交易，合计成交601.65万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000001917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645989023","title":"6月22日新光药业现1笔折价20.61%的大宗交易 合计成交228.62万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645989023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645989023?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:37","pubTimestamp":1782121058,"startTime":"0","endTime":"0","summary":"证券之星消息，6月22日新光药业发生大宗交易，交易数据如下：大宗交易成交价格9.94元，相对当日收盘价折价20.61%，成交23万股，成交金额228.62万元，买方营业部为国泰海通证券股份有限公司嵊州高杨路证券营业部，卖方营业部为国泰海通证券股份有限公司嵊州高杨路证券营业部。近三个月该股共发生8笔大宗交易，合计成交2.37万手，折价成交8笔。截至2026年6月22日收盘，新光药业报收于12.52元，上涨0.81%，换手率2.15%，成交量2.46万手，成交额3004.97万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200025952.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","300519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645096267","title":"每周股票复盘：新光药业（300519）股东减持213.7万股占总股本1.3356%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645096267","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645096267?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:28","pubTimestamp":1781983691,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，新光药业报收于12.42元，较上周的13.04元下跌4.75%。本周关注点股本股东变化：股东和丰投资减持213.7万股，占总股本1.3356%公司公告汇总：本次减持为已披露计划内操作，未违反相关承诺股本股东变化股东增减持6月15日新光药业发布公告，股东嵊州市和丰投资股份有限公司于2026年6月5日至6月12日间合计减持213.7万股，占公司目前总股本的1.3356%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100001157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300519"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643603270","title":"6月15日新光药业发布公告，股东减持213.7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643603270","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643603270?lang=zh_cn&edition=full","pubTime":"2026-06-15 19:01","pubTimestamp":1781521290,"startTime":"0","endTime":"0","summary":"证券之星消息，6月15日新光药业发布公告《新光药业:关于公司持股5%以上股东减持股份触及1%整倍数的公告》，其股东嵊州市和丰投资股份有限公司于2026年6月5日至2026年6月12日间合计减持213.7万股，占公司目前总股本的1.3356%，变动期间该股股价下跌1.58%，截止6月12日收盘报13.04元。股东增减持详情见下表：根据新光药业2026年一季报公布的十大股东详情如下：本文数据来源于新光药业公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500027237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300519","BK0132","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641192451","title":"6月5日新光药业现4笔折价21.54%的大宗交易 合计成交1339.84万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2641192451","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2641192451?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:32","pubTimestamp":1780651951,"startTime":"0","endTime":"0","summary":"证券之星消息，6月5日新光药业发生大宗交易，交易数据如下：近三个月该股共发生4笔大宗交易，合计成交1.26万手，折价成交4笔。该股近期无解禁股上市。截至2026年6月5日收盘，新光药业(300519)报收于13.51元，上涨1.96%，换手率1.82%，成交量2.08万手，成交额2783.37万元。该股近半年内有股东持股变动，合计净减持118.11万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500030283.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300519","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637337412","title":"新光药业（300519）披露2025年年度权益分派实施公告，5月21日股价下跌3.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637337412","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2637337412?lang=zh_cn&edition=full","pubTime":"2026-05-21 23:00","pubTimestamp":1779375647,"startTime":"0","endTime":"0","summary":"截至2026年5月21日收盘，新光药业报收于15.01元，较前一交易日下跌3.47%，最新总市值为24.02亿元。该股当日开盘15.68元，最高15.85元，最低14.96元，成交额达3773.05万元，换手率为2.15%。近日，公司发布《2025年年度权益分派实施公告》。公告显示，公司2025年年度权益分派方案为：以公司总股本160,000,000股为基数，向全体股东每10股派发现金红利3.00元（含税），合计派发现金红利48,000,000.00元（含税）。股权登记日为2026年5月28日，除权除息日为2026年5月29日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052100044998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","300519"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1790420585602,"stockEarnings":[{"period":"1week","weight":0.0467},{"period":"1month","weight":-0.0459},{"period":"3month","weight":0.2205},{"period":"6month","weight":-0.0367},{"period":"1year","weight":-0.0515},{"period":"ytd","weight":-0.0018}],"compareEarnings":[{"period":"1week","weight":0.0033},{"period":"1month","weight":-0.0003},{"period":"3month","weight":-0.0345},{"period":"6month","weight":-0.0065},{"period":"1year","weight":0.009},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江新光药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"13622人(较上一季度减少8.76%)","perCapita":"8376股","listingDate":"2016-06-24","address":"浙江省绍兴市嵊州市剡湖街道环城西路25号","registeredCapital":"16000万元","survey":" 浙江新光药业股份有限公司的主营业务是中成药、化学药、保健食品的研发、生产和销售。公司的主要产品是黄芪生脉饮、伸筋丹胶囊、西洋参口服液。","listedPrice":12.2},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"新光药业(300519)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供新光药业(300519)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"新光药业,300519,新光药业股票,新光药业股票老虎,新光药业股票老虎国际,新光药业行情,新光药业股票行情,新光药业股价,新光药业股市,新光药业股票价格,新光药业股票交易,新光药业股票购买,新光药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"新光药业(300519)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供新光药业(300519)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}